ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1157

Delay in Diagnosis from Onset of Symptoms By More Than One Year in 31% of Patients with Different Rheumatic Diseases in Australia

Isabel Castrejón1, Kathryn A. Gibson2 and Theodore Pincus1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Liverpool Hospital, Liverpool, Australia

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: diagnosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Health Services Research

Session Type: Abstract Submissions (ACR)

Background/Purpose: Early treatment is regarded as critical for optimal clinical outcomes in patients with inflammatory rheumatic diseases. However, delayed diagnosis is recognized in many rheumatic diseases.  We studied possible delay in diagnosis in routine care in a rheumatology teaching hospital in 2013, using a simple 1-page form completed by the rheumatologist.

Methods: All patients seen in the study setting complete a multidimensional health assessment questionnaire (MDHAQ) at each visit in the waiting area before seeing  the rheumatologist. The rheumatologist completes a complementary doctor form (RHEUMDOC). RHEUMDOC includes entry of 3 possible rheumatic diagnoses, queried for year of onset of symptoms and year of diagnosis. For this study, patients were classified into 4 groups according to diagnosis: rheumatoid arthritis (RA), osteoarthritis (OA), other inflammatory diseases (INF), and other non-inflammatory diseases (NON); differences between groups were compared using Wilcoxon rank sum tests.

Results: Among 211 patients seen between February and December 2013, 145 (69%) reported establishment of a diagnosis within one year, including 81% with RA, 55% with OA, 70% with other INF, and 57% with other NON (Table). The delay in RA was significantly less than in OA (p=0.0046). Nonetheless, 10% of RA patients received a diagnosis 1-5 years, and 8% >5 years, after symptom onset.  Among all patients,  13% of RA patients received a diagnosis 1-5 years after onset of symptoms, and 18% after more than 5 years after onset of symptoms. 

Diagnosis

Number of patients

Number of patients in each group according to interval from onset of symptoms to diagnosis

<1 year

N (%)

1-5 years

N (%)

>5 years

N (%)

RA

59

48 (81%)

6 (10%)

5 (8%)

OA

45

25 (55%)

10 (22%)

10 (22%)

Other INF

86

60 (70%)

8 (9%)

18 (21%)

Other Non-INF

21

12 (57%)

4 (19%)

5 (24%)

Total

211

145 (69%)

28 (13%)

38 (18%)

Conclusion: A delay from onset of symptoms to definitive diagnosis remains an important problem in rheumatic diseases. Delay in diagnosis more than 1 year is more common in patients with diseases other than RA, but remains in more than 30% of all patients and 19% of RA patients. Identification of specific contributors to this delay could inform education of both patients and physicians regarding the importance of early diagnosis and treatment, and health policy resources to facilitate timely management of rheumatic diseases.


Disclosure:

I. Castrejón,
None;

K. A. Gibson,
None;

T. Pincus,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/delay-in-diagnosis-from-onset-of-symptoms-by-more-than-one-year-in-31-of-patients-with-different-rheumatic-diseases-in-australia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology